位置:首页 > 蛋白库 > FABG_SYNY3
FABG_SYNY3
ID   FABG_SYNY3              Reviewed;         247 AA.
AC   P73574;
DT   15-DEC-1998, integrated into UniProtKB/Swiss-Prot.
DT   01-FEB-1997, sequence version 1.
DT   03-AUG-2022, entry version 138.
DE   RecName: Full=3-oxoacyl-[acyl-carrier-protein] reductase {ECO:0000303|PubMed:26358291};
DE            EC=1.1.1.100 {ECO:0000305|PubMed:26358291};
DE   AltName: Full=3-ketoacyl-acyl carrier protein reductase;
GN   Name=fabG; OrderedLocusNames=slr0886;
OS   Synechocystis sp. (strain PCC 6803 / Kazusa).
OC   Bacteria; Cyanobacteria; Synechococcales; Merismopediaceae; Synechocystis;
OC   unclassified Synechocystis.
OX   NCBI_TaxID=1111708;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=PCC 6803 / Kazusa;
RX   PubMed=8905231; DOI=10.1093/dnares/3.3.109;
RA   Kaneko T., Sato S., Kotani H., Tanaka A., Asamizu E., Nakamura Y.,
RA   Miyajima N., Hirosawa M., Sugiura M., Sasamoto S., Kimura T., Hosouchi T.,
RA   Matsuno A., Muraki A., Nakazaki N., Naruo K., Okumura S., Shimpo S.,
RA   Takeuchi C., Wada T., Watanabe A., Yamada M., Yasuda M., Tabata S.;
RT   "Sequence analysis of the genome of the unicellular cyanobacterium
RT   Synechocystis sp. strain PCC6803. II. Sequence determination of the entire
RT   genome and assignment of potential protein-coding regions.";
RL   DNA Res. 3:109-136(1996).
RN   [2] {ECO:0007744|PDB:4RZH}
RP   X-RAY CRYSTALLOGRAPHY (2.20 ANGSTROMS), FUNCTION, BIOTECHNOLOGY, AND
RP   MUTAGENESIS OF ALA-14; PRO-151; LYS-160; PHE-188 AND ASN-198.
RX   PubMed=26358291; DOI=10.1016/j.febslet.2015.09.001;
RA   Liu Y., Feng Y., Cao X., Li X., Xue S.;
RT   "Structure-directed construction of a high-performance version of the
RT   enzyme FabG from the photosynthetic microorganism Synechocystis sp. PCC
RT   6803.";
RL   FEBS Lett. 589:3052-3057(2015).
CC   -!- FUNCTION: Catalyzes the NADPH-dependent reduction of beta-ketoacyl-ACP
CC       substrates to beta-hydroxyacyl-ACP products, the first reductive step
CC       in the elongation cycle of fatty acid biosynthesis (Probable). Is
CC       capable of reducing acetoacetyl-CoA, but less well than its paralog
CC       PhaB (PubMed:26358291). {ECO:0000269|PubMed:26358291,
CC       ECO:0000305|PubMed:26358291}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=a (3R)-hydroxyacyl-[ACP] + NADP(+) = a 3-oxoacyl-[ACP] + H(+)
CC         + NADPH; Xref=Rhea:RHEA:17397, Rhea:RHEA-COMP:9916, Rhea:RHEA-
CC         COMP:9945, ChEBI:CHEBI:15378, ChEBI:CHEBI:57783, ChEBI:CHEBI:58349,
CC         ChEBI:CHEBI:78776, ChEBI:CHEBI:78827; EC=1.1.1.100;
CC         Evidence={ECO:0000305|PubMed:26358291};
CC   -!- PATHWAY: Lipid metabolism; fatty acid biosynthesis.
CC   -!- BIOTECHNOLOGY: Mutation of key residues to match those found in its
CC       paralog PhaB increases it activity on acetoacetyl-CoA, not its usual
CC       substrate, which might help shift cellular metabolism to make poly(3-
CC       hydroxybutyrate) (PHB), a compound that has potential uses as a
CC       renewable, biodegradable thermoplastic (PubMed:26358291). Poly(3-
CC       hydroxyalkanoic acids) (PHA), of which PHB is among the most common
CC       compounds, are prokaryotic intracellular storage compounds with
CC       potential uses as a renewable, biodegradable thermoplastic.
CC       Cyanobacterial PHB synthesis is particularly attractive as
CC       cyanobacteria use CO(2) as the carbon source.
CC       {ECO:0000269|PubMed:26358291}.
CC   -!- SIMILARITY: Belongs to the short-chain dehydrogenases/reductases (SDR)
CC       family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; BA000022; BAA17614.1; -; Genomic_DNA.
DR   PIR; S77280; S77280.
DR   PDB; 4RZH; X-ray; 2.20 A; A/B=1-247.
DR   PDBsum; 4RZH; -.
DR   AlphaFoldDB; P73574; -.
DR   SMR; P73574; -.
DR   IntAct; P73574; 1.
DR   STRING; 1148.1652694; -.
DR   PaxDb; P73574; -.
DR   EnsemblBacteria; BAA17614; BAA17614; BAA17614.
DR   KEGG; syn:slr0886; -.
DR   eggNOG; COG1028; Bacteria.
DR   InParanoid; P73574; -.
DR   OMA; KMPERDY; -.
DR   PhylomeDB; P73574; -.
DR   UniPathway; UPA00094; -.
DR   Proteomes; UP000001425; Chromosome.
DR   GO; GO:0004316; F:3-oxoacyl-[acyl-carrier-protein] reductase (NADPH) activity; IEA:UniProtKB-EC.
DR   GO; GO:0051287; F:NAD binding; IEA:InterPro.
DR   GO; GO:0016616; F:oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor; IBA:GO_Central.
DR   GO; GO:0030497; P:fatty acid elongation; IBA:GO_Central.
DR   InterPro; IPR011284; 3oxo_ACP_reduc.
DR   InterPro; IPR036291; NAD(P)-bd_dom_sf.
DR   InterPro; IPR020904; Sc_DH/Rdtase_CS.
DR   InterPro; IPR002347; SDR_fam.
DR   PRINTS; PR00081; GDHRDH.
DR   PRINTS; PR00080; SDRFAMILY.
DR   SUPFAM; SSF51735; SSF51735; 1.
DR   TIGRFAMs; TIGR01830; 3oxo_ACP_reduc; 1.
DR   PROSITE; PS00061; ADH_SHORT; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Fatty acid biosynthesis; Fatty acid metabolism;
KW   Lipid biosynthesis; Lipid metabolism; NADP; Oxidoreductase;
KW   Reference proteome.
FT   CHAIN           1..247
FT                   /note="3-oxoacyl-[acyl-carrier-protein] reductase"
FT                   /id="PRO_0000054691"
FT   ACT_SITE        156
FT                   /note="Proton acceptor"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU10001"
FT   BINDING         11..35
FT                   /ligand="NADP(+)"
FT                   /ligand_id="ChEBI:CHEBI:58349"
FT                   /evidence="ECO:0000250"
FT   BINDING         143
FT                   /ligand="substrate"
FT                   /evidence="ECO:0000250"
FT   MUTAGEN         14
FT                   /note="A->G: 4.2-fold increase in activity on acetoacetyl-
FT                   CoA."
FT                   /evidence="ECO:0000269|PubMed:26358291"
FT   MUTAGEN         151
FT                   /note="P->F: 2.7-fold increase in activity on acetoacetyl-
FT                   CoA."
FT                   /evidence="ECO:0000269|PubMed:26358291"
FT   MUTAGEN         151
FT                   /note="P->V: 5.7-fold increase in activity on acetoacetyl-
FT                   CoA."
FT                   /evidence="ECO:0000269|PubMed:26358291"
FT   MUTAGEN         160
FT                   /note="K->A: Almost no activity on acetoacetyl-CoA."
FT                   /evidence="ECO:0000269|PubMed:26358291"
FT   MUTAGEN         188
FT                   /note="F->Y: 3.3-fold increase in activity on acetoacetyl-
FT                   CoA."
FT                   /evidence="ECO:0000269|PubMed:26358291"
FT   MUTAGEN         198
FT                   /note="N->R: 3.5-fold increase in activity on acetoacetyl-
FT                   CoA."
FT                   /evidence="ECO:0000269|PubMed:26358291"
FT   HELIX           4..6
FT                   /evidence="ECO:0007829|PDB:4RZH"
FT   STRAND          8..13
FT                   /evidence="ECO:0007829|PDB:4RZH"
FT   HELIX           17..28
FT                   /evidence="ECO:0007829|PDB:4RZH"
FT   STRAND          32..39
FT                   /evidence="ECO:0007829|PDB:4RZH"
FT   HELIX           41..53
FT                   /evidence="ECO:0007829|PDB:4RZH"
FT   STRAND          57..62
FT                   /evidence="ECO:0007829|PDB:4RZH"
FT   HELIX           68..82
FT                   /evidence="ECO:0007829|PDB:4RZH"
FT   STRAND          87..90
FT                   /evidence="ECO:0007829|PDB:4RZH"
FT   HELIX           100..102
FT                   /evidence="ECO:0007829|PDB:4RZH"
FT   HELIX           105..115
FT                   /evidence="ECO:0007829|PDB:4RZH"
FT   HELIX           117..132
FT                   /evidence="ECO:0007829|PDB:4RZH"
FT   STRAND          137..141
FT                   /evidence="ECO:0007829|PDB:4RZH"
FT   HELIX           144..148
FT                   /evidence="ECO:0007829|PDB:4RZH"
FT   HELIX           154..174
FT                   /evidence="ECO:0007829|PDB:4RZH"
FT   HELIX           175..177
FT                   /evidence="ECO:0007829|PDB:4RZH"
FT   STRAND          180..186
FT                   /evidence="ECO:0007829|PDB:4RZH"
FT   HELIX           203..205
FT                   /evidence="ECO:0007829|PDB:4RZH"
FT   HELIX           214..226
FT                   /evidence="ECO:0007829|PDB:4RZH"
FT   HELIX           228..232
FT                   /evidence="ECO:0007829|PDB:4RZH"
FT   STRAND          237..241
FT                   /evidence="ECO:0007829|PDB:4RZH"
SQ   SEQUENCE   247 AA;  25724 MW;  91EBF9409C777F20 CRC64;
     MTALTAQVAL VTGASRGIGK ATALALAATG MKVVVNYAQS STAADAVVAE IIANGGEAIA
     VQANVANADE VDQLIKTTLD KFSRIDVLVN NAGITRDTLL LRMKLEDWQA VIDLNLTGVF
     LCTKAVSKLM LKQKSGRIIN ITSVAGMMGN PGQANYSAAK AGVIGFTKTV AKELASRGVT
     VNAVAPGFIA TDMTENLNAE PILQFIPLAR YGQPEEVAGT IRFLATDPAA AYITGQTFNV
     DGGMVMF
 
 
维奥蛋白资源库 - 中文蛋白资源 CopyRight © 2010-2024